ASX:CHM – Strategic $6.6M Capital Raise to Accelerate Clinical Trial Development
Chimeric Therapeutics has secured significant funding through a strongly supported placement, demonstrating market confidence in its innovative cell therapy programs.…
Ads Blocker Detected!!!
We have detected that you are using extensions to block ads. Please support us by disabling these ads blocker.
